Zinc finger protein Zfp335 is required for the formation of the naïve T cell compartment

Yuyuan Han, Shuang Wu, Chuan-Sheng Foo, Robert M. Horton, Craig N. Jenne, Susan R. Watson, Belinda Whittle, Christopher C. Goodnow, Jason G. CystereLife 2014 · DOI

TL;DR

Researchers have identified a novel transcription factor, Zfp335, crucial for the proper development and maturation of naïve T cells. A specific mutation in Zfp335 leads to a deficiency in these vital immune cells, impacting their ability to form a functional compartment. This discovery sheds light on a critical regulatory pathway in T cell development and opens avenues for understanding human immunodeficiencies.

What Problem Does This Paper Address?

The generation of a robust population of naïve T cells is fundamental for a healthy immune system. These cells are the "first responders," ready to identify and combat a vast array of pathogens. While we understand much about the early stages of T cell development in the thymus, the intricate mechanisms governing the final maturation of T cells, both within the thymus and as they enter the periphery, remain less clear. Specifically, the precise molecular regulators that ensure the production of sufficient numbers of functional, long-lived naïve T cells are not fully elucidated. This paper addresses this gap by investigating a mouse mutant with a T cell deficiency to uncover the underlying genetic cause and its role in T cell maturation.

Methods

The study employed a multi-pronged approach:

  • Mutagenesis Screen: An ethylnitrosourea (ENU) mutagenesis screen was used to identify mouse mutants with altered lymphocyte populations.
  • Genetic Mapping and Sequencing: The genetic lesion responsible for the observed T cell deficiency was mapped using SNP analysis and confirmed via whole-exome sequencing and Sanger sequencing.
  • Flow Cytometry: This was a cornerstone technique used extensively to analyze various T cell populations (DN, DP, CD4SP, CD8SP, naïve, effector/memory) in the thymus and periphery, assessing cell frequencies, phenotypes (CD44, CD62L, CD24), and cell cycle status.
  • ChIP-seq (Chromatin Immunoprecipitation Sequencing): This technique was used to identify the genomic regions where Zfp335 binds in thymocytes, revealing its direct target genes.
  • RNA Sequencing (Microarray): Gene expression profiling was performed on mature CD4SP thymocytes to identify genes whose expression is altered in the mutant mice.
  • Quantitative RT-PCR (qRT-PCR): Used to validate gene expression changes identified by microarray and to assess the expression of specific target genes.
  • Western Blotting: Employed to detect and quantify Zfp335 protein levels and the expression of its target genes (e.g., Ankle2).
  • Bone Marrow Chimeras: Used to assess the cell-intrinsic nature of the Zfp335 defect and to test gene complementation.
  • Adoptive Transfers: Used to study the maintenance and survival of T cells in vivo, particularly recent thymic emigrants (RTEs).
  • BrdU Labeling: Used to assess cell proliferation and turnover.
  • FTY720 Treatment: Used to block thymic egress and study the accumulation of mature SP thymocytes.
  • Electrophoretic Mobility Shift Assay (EMSA): Used to demonstrate direct DNA binding of Zfp335 to a specific motif in vitro.
  • Protein Structural Modeling: Used to predict the structural impact of the identified mutation.

Datasets

The study generated and utilized several datasets:

  • Newly Generated Datasets:
    • Gene expression profiling of mature CD4 SP thymocytes from wild-type and Zfp335 mutant mice (deposited in NCBI's Gene Expression Omnibus under SuperSeries GSE58293).
  • Gene expression profiling of recent thymic emigrants (RTEs) from wild-type and Zfp335 mutant mice (deposited in NCBI's Gene Expression Omnibus under SuperSeries GSE58293).
  • Zfp335 ChIP-seq data in wild-type and bloto/bloto thymocytes (deposited in NCBI's Gene Expression Omnibus under SuperSeries GSE58293).
  • Previously Published Datasets:
    • Histone modification ChIP-seq data (H3K4me3, H3K27ac, H3K27me3) for mouse thymus from ENCODE/LICR.
  • DNase I-seq data for mouse thymus from ENCODE/UW.

Key Insights and Ideas

  • Zfp335 is a critical regulator of naïve T cell maturation: The study firmly establishes Zfp335 as an essential transcription factor for the proper development of naïve T cells, particularly in the later stages of intrathymic and post-thymic maturation.
  • A hypomorphic mutation causes a selective T cell defect: The identified bloto mutation in Zfp335 is a hypomorphic allele, meaning it reduces but doesn't eliminate protein function. This leads to a specific deficiency in naïve T cells, rather than a complete block or a defect in all immune lineages.
  • The defect extends to recent thymic emigrants (RTEs): The study highlights that the maturation defect isn't confined to the thymus but also affects T cells shortly after they leave, impacting their survival and integration into the peripheral pool.
  • Zfp335 acts as a transcription factor binding to promoter regions: ChIP-seq data reveals that Zfp335 binds to active gene promoters, suggesting its primary role is in regulating gene transcription.
  • A novel DNA-binding motif for Zfp335 was identified: The researchers characterized a specific DNA sequence motif that Zfp335 recognizes, providing a molecular basis for its transcriptional regulatory function.
  • Ankle2 is a key downstream target: The study identifies Ankle2 as a significant target gene of Zfp335, and restoring Ankle2 expression partially rescues the T cell maturation defect, underscoring its functional importance.
  • Multigenic effects contribute to the phenotype: The bloto mutation's impact is not solely due to a single gene but likely involves dysregulation of multiple downstream targets, contributing to the observed T cell deficiency.

Key Results

  • Zfp335(bloto/bloto) mice exhibit a significant reduction in peripheral CD4+ and CD8+ naïve T cells (approximately 5-8 fold decrease).
  • Thymic analysis revealed a specific underrepresentation of mature single-positive (SP) thymocytes (approximately 1.8-2.3 fold decrease).
  • The bloto mutation is a missense mutation (R1092W) in the 12th zinc finger of Zfp335, affecting a conserved residue important for DNA binding.
  • Zfp335 binds to promoter regions of genes involved in protein metabolism, mitochondrial function, and transcriptional regulation.
  • ChIP-seq identified 157 Zfp335 binding regions in wild-type thymocytes, with 141 detected in bloto/bloto thymocytes, indicating a subset of target sites show reduced Zfp335 binding.
  • Genes like Ankle2, Nme6, and Mrps5 showed decreased Zfp335 binding in mutant mice.
  • Restoring Zfp335 expression in bloto/bloto bone marrow chimeras rescued the T cell maturation defect.
  • Exogenous expression of Ankle2 partially rescued the peripheral T cell maturation defect in bloto/bloto mice.

Limitations and Future Work

  • Hypomorphic nature of the mutation: The study focuses on a hypomorphic mutation, meaning Zfp335 retains some function. The full impact of a complete null mutation (which is embryonic lethal) remains to be explored.
  • Subtle gene expression changes: While Zfp335 binding was reduced at some sites, the corresponding gene expression changes were often mild. The authors suggest this might be due to the limitations of ChIP-seq sensitivity or the fact that the most affected cells (mature CD4SP thymocytes) are a small fraction of the total thymocyte population.
  • Multigenic regulation: The phenotype is likely due to the dysregulation of multiple Zfp335 target genes, making it challenging to pinpoint the exact contribution of each.
  • Cell type specificity: While the defect appears selective for T cells, the authors note that some target genes might be dysregulated in other immune cell types, suggesting broader roles for Zfp335.
  • Future Directions:
    • Further defining how Zfp335 controls gene expression and identifying its full set of target genes.
  • Investigating whether mutations in Zfp335 contribute to human T-cell immunodeficiencies.
  • Understanding the precise function of Ankle2 in T cell maturation.
  • Exploring the role of Zfp335 in other developmental processes and immune regulation.
  • Investigating the interaction partners of Zfp335 and how its function is regulated.

Summary updated

Abstract

The generation of naïve T lymphocytes is critical for immune function yet the mechanisms governing their maturation remain incompletely understood. We have identified a mouse mutant, bloto, that harbors a hypomorphic mutation in the zinc finger protein Zfp335. Zfp335(bloto/bloto) mice exhibit a naïve T cell deficiency due to an intrinsic developmental defect that begins to manifest in the thymus and continues into the periphery, affecting T cells that have recently undergone thymic egress. The effects of Zfp335(bloto) are multigenic and cannot be attributed to altered thymic selection, proliferation or Bcl2-dependent survival. Zfp335 binds to promoter regions via a consensus motif, and its target genes are enriched in categories related to protein metabolism, mitochondrial function, and transcriptional regulation. Restoring the expression of one target, Ankle2, partially rescues T cell maturation. These findings identify Zfp335 as a transcription factor and essential regulator of late-stage intrathymic and post-thymic T cell maturation.
BibTeX
@inproceedings{han2014zinc,
  author = {Yuyuan Han and Shuang Wu and Chuan-Sheng Foo and Robert M. Horton and Craig N. Jenne and Susan R. Watson and Belinda Whittle and Christopher C. Goodnow and Jason G. Cyster},
  title = {{Zinc finger protein Zfp335 is required for the formation of the naïve T cell compartment}},
  booktitle = {eLife},
  year = {2014},
  doi = {10.7554/elife.03549},
}
Figure